Literature DB >> 20544925

Vascular pathology in dermatomyositis and anatomic relations to myopathology.

Alan Pestronk1, Robert E Schmidt, Rati Choksi.   

Abstract

The causes of perifascicular myofiber atrophy and capillary pathology in dermatomyositis are incompletely understood. We studied 11 dermatomyositis muscles by histochemistry, immunohistochemistry, and ultrastructure. We found that endomysial capillaries within regions of perifascicular atrophy are not entirely lost, but they have reduced size, endothelial loss, C5b9 complement deposits, and relatively preserved connective tissue molecules and pericytes. In all muscles, the perimysium varies regionally. Some areas contain intermediate-sized vessels. Others are avascular. In dermatomyositis, vascular perimysium contains abnormal vessel fragments, perivascular inflammation, and increased PECAM-1. Perifascicular myofiber atrophy and capillary pathology are concentrated near the avascular perimysium. We conclude that both perimysial intermediate-sized vessels and endomysial capillaries within regions of perifascicular myofiber atrophy are abnormal in dermatomyositis. Capillary damage and myofiber atrophy are concentrated in regions distant from intermediate-sized perimysial vessels. Chronic immune vascular damage and insufficiency in dermatomyositis may cause ischemia, myofiber atrophy, and capillary damage in "watershed" regions of muscle near the avascular perimysium.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20544925     DOI: 10.1002/mus.21651

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  11 in total

Review 1.  Clinical features, pathogenesis and treatment of juvenile and adult dermatomyositis.

Authors:  Angela B Robinson; Ann M Reed
Journal:  Nat Rev Rheumatol       Date:  2011-09-27       Impact factor: 20.543

Review 2.  Autoimmune myopathies: autoantibodies, phenotypes and pathogenesis.

Authors:  Andrew L Mammen
Journal:  Nat Rev Neurol       Date:  2011-06-08       Impact factor: 42.937

3.  The chromatin-remodeling enzymes BRG1 and CHD4 antagonistically regulate vascular Wnt signaling.

Authors:  Carol D Curtis; Courtney T Griffin
Journal:  Mol Cell Biol       Date:  2012-01-30       Impact factor: 4.272

Review 4.  Idiopathic inflammatory myopathies.

Authors:  Ingrid E Lundberg; Manabu Fujimoto; Jiri Vencovsky; Rohit Aggarwal; Marie Holmqvist; Lisa Christopher-Stine; Andrew L Mammen; Frederick W Miller
Journal:  Nat Rev Dis Primers       Date:  2021-12-02       Impact factor: 52.329

5.  Office based muscle biopsy using Vacora vacuum assisted biopsy system.

Authors:  S N Akarolo-Anthony; T O Ogundiran; C Nkwodimmah; A Famooto; A S Famooto; J Adediji; C N Rotimi; W Balogun; J Adeleye; C A Adebamowo
Journal:  Afr J Med Med Sci       Date:  2012-09

Review 6.  Idiopathic inflammatory myopathies.

Authors:  Mazen M Dimachkie; Richard J Barohn; Anthony A Amato
Journal:  Neurol Clin       Date:  2014-08       Impact factor: 3.806

Review 7.  Idiopathic inflammatory myopathies.

Authors:  Mazen M Dimachkie; Richard J Barohn
Journal:  Semin Neurol       Date:  2012-11-01       Impact factor: 3.420

Review 8.  Idiopathic Inflammatory Myopathies: Clinical Approach and Management.

Authors:  Asma Malik; Ghazala Hayat; Junaid S Kalia; Miguel A Guzman
Journal:  Front Neurol       Date:  2016-05-20       Impact factor: 4.003

9.  Immune myopathies with perimysial pathology: Clinical and laboratory features.

Authors:  Robert C Bucelli; Alan Pestronk
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2018-01-17

10.  Differential roles of hypoxia and innate immunity in juvenile and adult dermatomyositis.

Authors:  Corinna Preuße; Yves Allenbach; Olaf Hoffmann; Hans-Hilmar Goebel; Debora Pehl; Josefine Radke; Alexandra Doeser; Udo Schneider; Rieke H E Alten; Tilmann Kallinich; Olivier Benveniste; Arpad von Moers; Benedikt Schoser; Ulrike Schara; Werner Stenzel
Journal:  Acta Neuropathol Commun       Date:  2016-04-27       Impact factor: 7.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.